Review

You have free access to this content

The Immunopathology of Sepsis: Pathogen Recognition, Systemic Inflammation, the Compensatory Anti-Inflammatory Response, and Regulatory T Cells

D.H. Lewis^1,†,
D.L. Chan¹,
D. Pinheiro²,
E. Armitage-Chan³,
O.A. Garden^1,2,*

Article first published online: 17 MAR 2012

DOI: 10.1111/j.1939-1676.2012.00905.x

Issue

Journal of Veterinary Internal Medicine

Volume 26, Issue 3, pages 457–482, May-June 2012

Additional Information

How to Cite

Lewis, D.H., Chan, D.L., Pinheiro, D., Armitage-Chan, E. and Garden, O.A. (2012), The Immunopathology of Sepsis: Pathogen Recognition, Systemic Inflammation, the Compensatory Anti-Inflammatory Response, and Regulatory T Cells. Journal of Veterinary Internal Medicine, 26: 457–482. doi: 10.1111/j.1939-1676.2012.00905.x

Author Information

¹
Department of Veterinary Clinical Sciences, The Royal Veterinary College, Hatfield Campus, Hertfordshire,, UK (Lewis, Chan, Garden)
²
Regulatory T Cell Laboratory, The Royal Veterinary College, Camden Campus, London, NW1 OTU, UK (Pinheiro, Garden)
³
Davies Veterinary Specialists, Manor Farm Business Park, Hertfordshire, SG5 3HR, UK (Armitage-Chan)

^†
Langford Veterinary Services, Small Animal Hospital, Langford, Bristol, BS40 5DU, UK

^*Corresponding author: O.A. Garden, Department of Veterinary Clinical Sciences, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK; e-mail: ogarden@rvc.ac.uk.

Publication History

Issue published online: 2 MAY 2012
Article first published online: 17 MAR 2012
Manuscript Accepted: 7 FEB 2012
Manuscript Revised: 28 NOV 2011
Manuscript Received: 30 NOV 2010

ARTICLE TOOLS

View Full Article (HTML) Get PDF (655K)

References

1
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–1655.
2
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138–150.
3
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–1256.
4
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530–538.
- PubMed
5
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006;34:344–353.
6
Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med 1996;17:175–181.
7
Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303–1310.
8
Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–1554.
9
Brady CA, Otto CM. Systemic inflammatory response syndrome, sepsis, and multiple organ dysfunction. Vet Clin North Am Small Anim Pract 2001;31:1147–1162, v-vi.
10
Hoffman AM, Staempfli HR, Willan A. Prognostic variables for survival of neonatal foals under intensive care. J Vet Intern Med 1992;6:89–95.
Direct Link:
11
Declue AE, Delgado C, Chang CH, et al. Clinical and immunologic assessment of sepsis and the systemic inflammatory response syndrome in cats. J Am Vet Med Assoc 2011;238:890–897.
12
Hurcombe SD, Toribio RE, Slovis NM, et al. Calcium regulating hormones and serum calcium and magnesium concentrations in septic and critically ill foals and their association with survival. J Vet Intern Med 2009;23:335–343.
Direct Link:
13
Rau S, Kohn B, Richter C, et al. Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol 2007;36:253–260.
Direct Link:
14
Chong DL, Sriskandan S. Pro-inflammatory mechanisms in sepsis. Contrib Microbiol 2011;17:86–107.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
15
Cinel I, Opal SM. Molecular biology of inflammation and sepsis: A primer. Crit Care Med 2009;37:291–304.
16
Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–891.
17
Ivady B, Beres BJ, Szabo D. Recent advances in sepsis research: Novel biomarkers and therapeutic targets. Curr Med Chem 2011;18:3211–3225.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
18
Remick DG. Pathophysiology of sepsis. Am J Pathol 2007;170:1435–1444.
19
Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol 2008;214:211–223.
Direct Link:
20
Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, et al. The pathogenesis of sepsis. Annu Rev Pathol 2011;6:19–48.
21
Ganz T, Weiss J. Antimicrobial peptides of phagocytes and epithelia. Semin Hematol 1997;34:343–354.
22
Hoffmann JA, Kafatos FC, Janeway CA, et al. Phylogenetic perspectives in innate immunity. Science 1999;284:1313–1318.
23
Zasloff M. Antimicrobial peptides in health and disease. N Engl J Med 2002;347:1199–1200.
24
Brogden KA, Ackermann M, McCray PB Jr, et al. Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents 2003;22:465–478.
25
Linde A, Ross CR, Davis EG, et al. Innate immunity and host defense peptides in veterinary medicine. J Vet Intern Med 2008;22:247–265.
Direct Link:
26
Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999;1462:55–70.
27
Wilmes M, Cammue BP, Sahl HG, et al. Antibiotic activities of host defense peptides: More to it than lipid bilayer perturbation. Nat Prod Rep 2011;28:1350–1358.
28
Ali AS, Townes CL, Hall J, et al. Maintaining a sterile urinary tract: The role of antimicrobial peptides. J Urol 2009;182:21–28.
29
Diamond G, Beckloff N, Ryan LK. Host defense peptides in the oral cavity and the lung: Similarities and differences. J Dent Res 2008;87:915–927.
30
Ham M, Kaunitz JD. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2008;24:665–673.
31
Laube DM, Yim S, Ryan LK, et al. Antimicrobial peptides in the airway. Curr Top Microbiol Immunol 2006;306:153–182.
- CrossRef,
- PubMed,
- CAS
32
Huttner KM, Brezinski-Caliguri DJ, Mahoney MM, et al. Antimicrobial peptide expression is developmentally regulated in the ovine gastrointestinal tract. J Nutr 1998;128:297S–299S.
33
Sang Y, Ortega MT, Blecha F, et al. Molecular cloning and characterization of three beta-defensins from canine testes. Infect Immun 2005;73:2611–2620.
34
Salaun B, de Saint-Vis B, Pacheco N, et al. CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes. Am J Pathol 2004;164:861–871.
35
Matzinger P. Friendly and dangerous signals: Is the tissue in control? Nat Immunol 2007;8:11–13.
36
Frantz S, Ertl G, Bauersachs J. Toll-like receptor signaling in the ischemic heart. Front Biosci 2008;13:5772–5779.
37
Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229–241.
38
Davies D, Meade KG, Herath S, et al. Toll-like receptor and antimicrobial peptide expression in the bovine endometrium. Reprod Biol Endocrinol 2008;6:53.
39
Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007;81:1–5.
40
Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114–119.
41
Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991–1045.
42
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801.
43
Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 2007;19:3–10.
44
Chen GY, Tang J, Zheng P, et al. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009;323:1722–1725.
45
Chun KH, Seong SY. CD14 but not MD2 transmit signals from DAMP. Int Immunopharmacol 2010;10:98–106.
46
Mollen KP, Anand RJ, Tsung A, et al. Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006;26:430–437.
47
Astakhova NM, Perelygin AA, Zharkikh AA, et al. Characterization of equine and other vertebrate TLR3, TLR7, and TLR8 genes. Immunogenetics 2009;61:529–539.
48
Chang JS, Russell GC, Jann O, et al. Molecular cloning and characterization of Toll-like receptors 1-10 in sheep. Vet Immunol Immunopathol 2009;127:94–105.
49
Ignacio G, Nordone S, Howard KE, et al. Toll-like receptor expression in feline lymphoid tissues. Vet Immunol Immunopathol 2005;106:229–237.
50
McGuire K, Jones M, Werling D, et al. Radiation hybrid mapping of all 10 characterized bovine Toll-like receptors. Anim Genet 2006;37:47–50.
Direct Link:
51
Menzies M, Ingham A. Identification and expression of Toll-like receptors 1-10 in selected bovine and ovine tissues. Vet Immunol Immunopathol 2006;109:23–30.
52
Tirumurugaan KG, Dhanasekaran S, Raj GD, et al. Differential expression of toll-like receptor mRNA in selected tissues of goat (Capra hircus). Vet Immunol Immunopathol 2010;133:296–301.
53
Turin L, Riva F. Toll-like receptor family in domestic animal species. Crit Rev Immunol 2008;28:513–538.
54
Werling D, Coffey TJ. Pattern recognition receptors in companion and farm animals ‒ The key to unlocking the door to animal disease? Vet J 2007;174:240–251.
55
Werling D, Jann OC, Offord V, et al. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol 2009;30:124–130.
56
Williams DL, Ha T, Li C, et al. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 2003;31:1808–1818.
57
Tsujimoto H, Ono S, Efron PA, et al. Role of Toll-like receptors in the development of sepsis. Shock 2008;29:315–321.
58
Sato S, Nomura F, Kawai T, et al. Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 2000;165:7096–7101.
59
Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009;21:38–46.
60
Kuroki K, Stoker AM, Sims HJ, et al. Expression of Toll-like receptors 2 and 4 in stifle joint synovial tissues of dogs with or without osteoarthritis. Am J Vet Res 2010;71:750–754.
61
Silva E, Leitao S, Henriques S, et al. Gene transcription of TLR2, TLR4, LPS ligands and prostaglandin synthesis enzymes are up-regulated in canine uteri with cystic endometrial hyperplasia-pyometra complex. J Reprod Immunol 2010;84:66–74.
62
Taraktsoglou M, Szalabska U, Magee DA, et al. Transcriptional profiling of immune genes in bovine monocyte-derived macrophages exposed to bacterial antigens. Vet Immunol Immunopathol 2011;140:130–139.
63
Gundersen Y, Vaagenes P, Thrane I, et al. Early time course of altered leukocyte response to lipopolysaccharide and peptidoglycan in porcine gunshot injury. Acta Anaesthesiol Scand 2008;52:1231–1237.
Direct Link:
64
Deitschel SJ, Kerl ME, Chang CH, et al. Age-associated changes to pathogen-associated molecular pattern-induced inflammatory mediator production in dogs. J Vet Emerg Crit Care (San Antonio) 2010;20:494–502.
Direct Link:
65
Benbarek H, Deby-Dupont G, Caudron I, et al. Interactions between lipopolysaccharides and blood factors on the stimulation of equine polymorphonuclear neutrophils. Vet Immunol Immunopathol 1998;64:313–322.
66
Declue AE, Johnson PJ, Day JL, et al. Pathogen associated molecular pattern motifs from Gram-positive and Gram-negative bacteria induce different inflammatory mediator profiles in equine blood. Vet J 2011;00:00–00.
67
Fowler BL, Axiak SM, Declue AE. Blunted pathogen-associated molecular pattern motif induced TNF, IL-6 and IL-10 production from whole blood in dogs with lymphoma. Vet Immunol Immunopathol 2011;144:167–171.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
68
Ishii KJ, Koyama S, Nakagawa A, et al. Host innate immune receptors and beyond: Making sense of microbial infections. Cell Host Microbe 2008;3:352–363.
69
Medzhitov R, Janeway C, Jr. Innate immune recognition: Mechanisms and pathways. Immunol Rev 2000;173:89–97.
Direct Link:
70
Zak DE, Aderem A. Systems biology of innate immunity. Immunol Rev 2009;227:264–282.
Direct Link:
71
Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637–650.
72
Koyama S, Ishii KJ, Kumar H, et al. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 2007;179:4711–4720.
73
Takahashi K, Kawai T, Kumar H, et al. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 2006;176:4520–4524.
74
Hashimoto C, Hudson KL, Anderson KV. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988;52:269–279.
75
Gay NJ, Keith FJ. Drosophila Toll and IL-1 receptor. Nature 1991;351:355–356.
76
Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999;285:732–736.
77
Lemaitre B, Nicolas E, Michaut L, et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973–983.
78
Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394–397.
79
Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443–451.
80
Horng T, Barton GM, Medzhitov R. TIRAP: An adapter molecule in the Toll signaling pathway. Nat Immunol 2001;2:835–841.
81
Jenkins KA, Mansell A. TIR-containing adaptors in Toll-like receptor signalling. Cytokine 2010;49:237–244.
82
Medzhitov R, Preston-Hurlburt P, Kopp E, et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998;2:253–258.
83
O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007;7:353–364.
84
West AP, Koblansky AA, Ghosh S. Recognition and signaling by Toll-like receptors. Annu Rev Cell Dev Biol 2006;22:409–437.
85
Kawagoe T, Sato S, Matsushita K, et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 2008;9:684–691.
86
Sato S, Sanjo H, Takeda K, et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005;6:1087–1095.
87
Aksoy E, Vanden Berghe W, Detienne S, et al. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4. Eur J Immunol 2005;35:2200–2209.
Direct Link:
88
Liljeroos M, Vuolteenaho R, Morath S, et al. Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cell Signal 2007;19:625–633.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
89
Ojaniemi M, Glumoff V, Harju K, et al. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol 2003;33:597–605.
Direct Link:
90
Cabanski M, Steinmuller M, Marsh LM, et al. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Am J Respir Cell Mol Biol 2008;38:26–31.
91
Lentschat A, Karahashi H, Michelsen KS, et al. Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages. J Immunol 2005;174:4252–4261.
92
Skokos D, Nussenzweig MC. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med 2007;204:1525–1531.
93
Sabroe I, Parker LC, Dower SK, et al. The role of TLR activation in inflammation. J Pathol 2008;214:126–135.
Direct Link:
94
Aldape MJ, Bryant AE, Katahira EJ, et al. Innate immune recognition of, and response to, Clostridium sordellii. Anaerobe 2010;16:125–130.
95
Netea MG, Kullberg BJ, Galama JM, et al. Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur J Immunol 2002;32:1188–1195.
Direct Link:
96
Schwandner R, Dziarski R, Wesche H, et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406–17409.
97
Zahringer U, Lindner B, Inamura S, et al. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008;213:205–224.
98
Lorne E, Dupont H, Abraham E. Toll-like receptors 2 and 4: Initiators of non-septic inflammation in critical care medicine? Intensive Care Med 2010;36:1826–1835.
99
Takeuchi O, Kawai T, Muhlradt PF, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001;13:933–940.
100
Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002;169:10–14.
101
Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749–3752.
102
Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145–151.
103
Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1–14.
104
Park BS, Song DH, Kim HM, et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009;458:1191–1195.
105
Andersen-Nissen E, Smith KD, Bonneau R, et al. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J Exp Med 2007;204:393–403.
106
Uematsu S, Fujimoto K, Jang MH, et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol 2008;9:769–776.
107
Liaudet L, Szabo C, Evgenov OV, et al. Flagellin from Gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock 2003;19:131–137.
108
Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J 2009;420:1–16.
109
Herskovits AA, Auerbuch V, Portnoy DA. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 2007;3:e51.
110
Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003;301:640–643.
111
Yarovinsky F, Zhang D, Andersen JF, et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005;308:1626–1629.
112
Zhang D, Zhang G, Hayden MS, et al. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303:1522–1526.
113
Carneiro LA, Magalhaes JG, Tattoli I, et al. Nod-like proteins in inflammation and disease. J Pathol 2008;214:136–148.
Direct Link:
114
Chamaillard M, Hashimoto M, Horie Y, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003;4:702–707.
115
Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869–8872.
116
Jones JD, Dangl JL. The plant immune system. Nature 2006;444:323–329.
117
Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007;27:549–559.
118
Franchi L, Warner N, Viani K, et al. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009;227:106–128.
Direct Link:
119
Inohara N, Chamaillard M, McDonald C, et al. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005;74:355–383.
120
Moore CB, Bergstralh DT, Duncan JA, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008;451:573–577.
121
Barnich N, Aguirre JE, Reinecker HC, et al. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-kappaB activation in muramyl dipeptide recognition. J Cell Biol 2005;170:21–26.
122
Kufer TA, Kremmer E, Adam AC, et al. The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol 2008;10:477–486.
123
Marina-Garcia N, Franchi L, Kim YG, et al. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J Immunol 2008;180:4050–4057.
124
Ratner AJ, Aguilar JL, Shchepetov M, et al. Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol 2007;9:1343–1351.
Direct Link:
125
Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004;5:1166–1174.
126
Hasegawa M, Fujimoto Y, Lucas PC, et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 2008;27:373–383.
127
Inohara N, Koseki T, del Peso L, et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 1999;274:14560–14567.
128
Kim JY, Omori E, Matsumoto K, et al. TAK1 is a central mediator of NOD2 signaling in epidermal cells. J Biol Chem 2008;283:137–144.
129
Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812–4818.
130
Strober W, Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol 2011;4:484–495.
131
Masumoto J, Yang K, Varambally S, et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 2006;203:203–213.
132
Cartwright N, Murch O, McMaster SK, et al. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. Am J Respir Crit Care Med 2007;175:595–603.
133
Lamkanfi M, Dixit VM. Inflammasomes: Guardians of cytosolic sanctity. Immunol Rev 2009;227:95–105.
Direct Link:
134
Lamkanfi M, Dixit VM. The inflammasomes. PLoS Pathog 2009;5:e1000510.
135
Martinon F, Burns K, Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417–426.
136
Franchi L, Amer A, Body-Malapel M, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 2006;7:576–582.
137
Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237–241.
138
Sutterwala FS, Mijares LA, Li L, et al. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med 2007;204:3235–3245.
139
Tsuji NM, Tsutsui H, Seki E, et al. Roles of caspase-1 in Listeria infection in mice. Int Immunol 2004;16:335–343.
140
Mariathasan S, Weiss DS, Dixit VM, et al. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 2005;202:1043–1049.
141
Sarkar A, Hall MW, Exline M, et al. Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am J Respir Crit Care Med 2006;174:1003–1010.
142
Saleh M, Mathison JC, Wolinski MK, et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006;440:1064–1068.
143
Saleh M, Vaillancourt JP, Graham RK, et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004;429:75–79.
144
Li P, Allen H, Banerjee S, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995;80:401–411.
145
Mariathasan S, Newton K, Monack DM, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004;430:213–218.
146
Fahy RJ, Exline MC, Gavrilin MA, et al. Inflammasome mRNA expression in human monocytes during early septic shock. Am J Respir Crit Care Med 2008;177:983–988.
147
Kempster SL, Belteki G, Forhead AJ, et al. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine. Am J Physiol Gastrointest Liver Physiol 2011;300:G253–G263.
148
Chen H, Li C, Fang M, et al. Understanding Haemophilus parasuis infection in porcine spleen through a transcriptomics approach. BMC Genomics 2009;10:64.
149
Li R, Zhang A, Chen B, et al. Response of swine spleen to Streptococcus suis infection revealed by transcription analysis. BMC Genomics 2010;11:556.
150
Swerdlow MP, Kennedy DR, Kennedy JS, et al. Expression and function of TLR2, TLR4, and Nod2 in primary canine colonic epithelial cells. Vet Immunol Immunopathol 2006;114:313–319.
151
Asahina Y, Yoshioka N, Kano R, et al. Full-length cDNA cloning of Toll-like receptor 4 in dogs and cats. Vet Immunol Immunopathol 2003;96:159–167.
152
Hashimoto M, Asahina Y, Sano J, et al. Cloning of canine Toll-like receptor 9 and its expression in dog tissues. Vet Immunol Immunopathol 2005;106:159–163.
153
Ishii M, Hashimoto M, Oguma K, et al. Molecular cloning and tissue expression of canine Toll-like receptor 2 (TLR2). Vet Immunol Immunopathol 2006;110:87–95.
154
Okui Y, Kano R, Maruyama H, et al. Cloning of canine Toll-like receptor 7 gene and its expression in dog tissues. Vet Immunol Immunopathol 2008;121:156–160.
155
Franchini M, Zini E, Osto M, et al. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs). Vet Immunol Immunopathol 2010;138:70–78.
156
Lehman TL, O'Halloran KP, Fallon SA, et al. Altered bone marrow dendritic cell cytokine production to Toll-like receptor and CD40 ligation during chronic feline immunodeficiency virus infection. Immunology 2009;126:405–412.
Direct Link:
157
Kwong LS, Parsons R, Patterson R, et al. Characterisation of antibodies to bovine Toll-like receptor (TLR)-2 and cross-reactivity with ovine TLR2. Vet Immunol Immunopathol 2011;139:313–318.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
158
Dhanasekaran S, Kannan TA, Dhinakar Raj G, et al. Differential expression of Toll-like receptor mRNA in corneal epithelium of ruminants. Vet Ophthalmol 2010;13:270–274.
Direct Link:
159
Bridger PS, Mohr M, Stamm I, et al. Primary bovine colonic cells: A model to study strain-specific responses to Escherichia coli. Vet Immunol Immunopathol 2010;137:54–63.
160
Farhat K, Riekenberg S, Jung G, et al. Identification of full length bovine TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer. Vet Res 2010;41:34.
161
Seabury CM, Seabury PM, Decker JE, et al. Diversity and evolution of 11 innate immune genes in Bos taurus taurus and Bos taurus indicus cattle. Proc Natl Acad Sci USA 2010;107:151–156.
162
Arsenault RJ, Jalal S, Babiuk LA, et al. Kinome analysis of Toll-like receptor signaling in bovine monocytes. J Recept Signal Transduct Res 2009;29:299–311.
163
Herath S, Lilly ST, Santos NR, et al. Expression of genes associated with immunity in the endometrium of cattle with disparate postpartum uterine disease and fertility. Reprod Biol Endocrinol 2009;7:55.
164
Mucha R, Bhide MR, Chakurkar EB, et al. Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle. Vet Immunol Immunopathol 2009;128:381–388.
165
Zhu J, Brownlie R, Liu Q, et al. Characterization of bovine Toll-like receptor 8: Ligand specificity, signaling essential sites and dimerization. Mol Immunol 2009;46:978–990.
166
Jann OC, Werling D, Chang JS, et al. Molecular evolution of bovine Toll-like receptor 2 suggests substitutions of functional relevance. BMC Evol Biol 2008;8:288.
167
Goldammer T, Zerbe H, Molenaar A, et al. Mastitis increases mammary mRNA abundance of beta-defensin 5, Toll-like-receptor 2 (TLR2), and TLR4 but not TLR9 in cattle. Clin Diagn Lab Immunol 2004;11:174–185.
168
Schneberger D, Lewis D, Caldwell S, et al. Expression of Toll-like receptor 9 in lungs of pigs, dogs and cattle. Int J Exp Pathol 2011;92:1–7.
Direct Link:
169
Jann OC, King A, Corrales NL, et al. Comparative genomics of Toll-like receptor signalling in five species. BMC Genomics 2009;10:216.
170
Mikula I Jr, Mikula I Sr, Characterization of ovine Toll-like receptor 9 protein coding region, comparative analysis, detection of mutations and maedi visna infection. Dev Comp Immunol 2011;35:182–192.
171
Plain KM, Purdie AC, Begg DJ, et al. Toll-like receptor (TLR)6 and TLR1 differentiation in gene expression studies of Johne's disease. Vet Immunol Immunopathol 2010;137:142–148.
172
Byun SO, Zhou H, Hickford JG. Development of a simple typing method for the ovine Toll-like receptor 4 gene. Vet Immunol Immunopathol 2009;130:272–274.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
173
Hillman NH, Moss TJ, Nitsos I, et al. Toll-like receptors and agonist responses in the developing fetal sheep lung. Pediatr Res 2008;63:388–393.
174
Raja A, Vignesh AR, Mary BA, et al. Sequence analysis of Toll-like receptor genes 1-10 of goat (Capra hircus). Vet Immunol Immunopathol 2011;140:252–258.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
175
Tourais-Esteves I, Bernardet N, Lacroix-Lamande S, et al. Neonatal goats display a stronger TH1-type cytokine response to TLR ligands than adults. Dev Comp Immunol 2008;32:1231–1241.
176
Gornik K, Moore P, Figueiredo M, et al. Expression of Toll-like receptors 2, 3, 4, 6, 9, and MD-2 in the normal equine cornea, limbus, and conjunctiva. Vet Ophthalmol 2011;14:80–85.
Direct Link:
177
Kwon S, Vandenplas ML, Figueiredo MD, et al. Differential induction of Toll-like receptor gene expression in equine monocytes activated by Toll-like receptor ligands or TNF-alpha. Vet Immunol Immunopathol 2010;138:213–217.
178
Berndt A, Derksen FJ, Venta PJ, et al. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. Am J Physiol Lung Cell Mol Physiol 2007;292:L936–943.
179
Singh Suri S, Janardhan KS, Parbhakar O, et al. Expression of Toll-like receptor 4 and 2 in horse lungs. Vet Res 2006;37:541–551.
180
Werners AH, Bull S, Vendrig JC, et al. Genotyping of Toll-like receptor 4, myeloid differentiation factor 2 and CD-14 in the horse: An investigation into the influence of genetic polymorphisms on the LPS induced TNF-alpha response in equine whole blood. Vet Immunol Immunopathol 2006;111:165–173.
181
Schneberger D, Caldwell S, Suri SS, et al. Expression of Toll-like receptor 9 in horse lungs. Anat Rec (Hoboken) 2009;292:1068–1077.
Direct Link:
182
Uenishi H, Shinkai H, Morozumi T, et al. Polymorphisms in pattern recognition receptors and their relationship to infectious disease susceptibility in pigs. BMC Proc 2011;5(Suppl 4):S27.
- CrossRef,
- PubMed
183
Shinkai H, Suzuki R, Akiba M, et al. Porcine Toll-like receptors: Recognition of Salmonella enterica serovar Choleraesuis and influence of polymorphisms. Mol Immunol 2011;48:1114–1120.
184
Evren S, Loai Y, Antoon R, et al. Urinary bladder tissue engineering using natural scaffolds in a porcine model: Role of Toll-like receptors and impact of biomimetic molecules. Cells Tissues Organs 2010;192:250–261.
185
Auray G, Facci MR, van Kessel J, et al. Differential activation and maturation of two porcine DC populations following TLR ligand stimulation. Mol Immunol 2010;47:2103–2111.
186
Morozumi T, Uenishi H. Polymorphism distribution and structural conservation in RNA-sensing Toll-like receptors 3, 7, and 8 in pigs. Biochim Biophys Acta 2009;1790:267–274.
187
Toka FN, Nfon CK, Dawson H, et al. Accessory-cell-mediated activation of porcine NK cells by Toll-like receptor 7 (TLR7) and TLR8 agonists. Clin Vaccine Immunol 2009;16:866–878.
188
Burkey TE, Skjolaas KA, Dritz SS, et al. Expression of porcine Toll-like receptor 2, 4 and 9 gene transcripts in the presence of lipopolysaccharide and Salmonella enterica serovars Typhimurium and Choleraesuis. Vet Immunol Immunopathol 2009;130:96–101.
189
Liu CH, Chaung HC, Chang HL, et al. Expression of Toll-like receptor mRNA and cytokines in pigs infected with porcine reproductive and respiratory syndrome virus. Vet Microbiol 2009;136:266–276.
190
Chaung HC, Chen CW, Hsieh BL, et al. Toll-like receptor expressions in porcine alveolar macrophages and dendritic cells in responding to poly IC stimulation and porcine reproductive and respiratory syndrome virus (PRRSV) infection. Comp Immunol Microbiol Infect Dis 2010;33:197–213.
191
Uenishi H, Shinkai H. Porcine Toll-like receptors: The front line of pathogen monitoring and possible implications for disease resistance. Dev Comp Immunol 2009;33:353–361.
192
Ibeagha-Awemu EM, Lee JW, Ibeagha AE, et al. Bacterial lipopolysaccharide induces increased expression of Toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells. Vet Res 2008;39:11.
193
Worku M, Morris A. Binding of different forms of lipopolysaccharide and gene expression in bovine blood neutrophils. J Dairy Sci 2009;92:3185–3193.
194
Cates EA, Connor EE, Mosser DM, et al. Functional characterization of bovine TIRAP and MyD88 in mediating bacterial lipopolysaccharide-induced endothelial NF-kappaB activation and apoptosis. Comp Immunol Microbiol Infect Dis 2009;32:477–490.
195
Gil LH, van Olphen AL, Mittal SK, et al. Modulation of PKR activity in cells infected by bovine viral diarrhea virus. Virus Res 2006;116:69–77.
196
Sen A, Pruijssers AJ, Dermody TS, et al. The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. J Virol 2011;85:3717–3732.
197
Bougarn S, Cunha P, Harmache A, et al. Muramyl dipeptide synergizes with Staphylococcus aureus lipoteichoic acid to recruit neutrophils in the mammary gland and to stimulate mammary epithelial cells. Clin Vaccine Immunol 2010;17:1797–1809.
198
Whelehan CJ, Meade KG, Eckersall PD, et al. Experimental Staphylococcus aureus infection of the mammary gland induces region-specific changes in innate immune gene expression. Vet Immunol Immunopathol 2011;140:181–189.
199
Purdie AC, Plain KM, Begg DJ, et al. Candidate gene and genome-wide association studies of Mycobacterium avium subsp. paratuberculosis infection in cattle and sheep: A review. Comp Immunol Microbiol Infect Dis 2011;34:197–208.
200
Fenhammar J, Rundgren M, Forestier J, et al. Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep. Anesthesiology 2011;114:1130–1137.
201
Alvarez B, Revilla C, Chamorro S, et al. Molecular cloning, characterization and tissue expression of porcine Toll-like receptor 4. Dev Comp Immunol 2006;30:345–355.
202
Alves MP, Neuhaus V, Guzylack-Piriou L, et al. Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets. Gene Ther 2007;14:836–844.
203
Moue M, Tohno M, Shimazu T, et al. Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. Biochim Biophys Acta 2008;1780:134–144.
204
Muneta Y, Uenishi H, Kikuma R, et al. Porcine TLR2 and TLR6: Identification and their involvement in Mycoplasma hyopneumoniae infection. J Interferon Cytokine Res 2003;23:583–590.
205
Shimosato T, Kitazawa H, Katoh S, et al. Swine Toll-like receptor 9(1) recognizes CpG motifs of human cell stimulant. Biochim Biophys Acta 2003;1627:56–61.
206
Shinkai H, Tanaka M, Morozumi T, et al. Biased distribution of single nucleotide polymorphisms (SNPs) in porcine Toll-like receptor 1 (TLR1), TLR2, TLR4, TLR5, and TLR6 genes. Immunogenetics 2006;58:324–330.
207
Shinkai H, Muneta Y, Suzuki K, et al. Porcine Toll-like receptor 1, 6, and 10 genes: Complete sequencing of genomic region and expression analysis. Mol Immunol 2006;43:1474–1480.
208
Thomas AV, Broers AD, Vandegaart HF, et al. Genomic structure, promoter analysis and expression of the porcine (Sus scrofa) TLR4 gene. Mol Immunol 2006;43:653–659.
209
Wassef A, Janardhan K, Pearce JW, et al. Toll-like receptor 4 in normal and inflamed lungs and other organs of pig, dog and cattle. Histol Histopathol 2004;19:1201–1208.
210
Miguel JC, Chen J, Van Alstine WG, et al. Expression of inflammatory cytokines and Toll-like receptors in the brain and respiratory tract of pigs infected with porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2010;135:314–319.
211
Sang Y, Yang J, Ross CR, et al. Molecular identification and functional expression of porcine Toll-like receptor (TLR) 3 and TLR7. Vet Immunol Immunopathol 2008;125:162–167.
212
Jozaki K, Shinkai H, Tanaka-Matsuda M, et al. Influence of polymorphisms in porcine NOD2 on ligand recognition. Mol Immunol 2009;47:247–252.
213
Kojima-Shibata C, Shinkai H, Morozumi T, et al. Differences in distribution of single nucleotide polymorphisms among intracellular pattern recognition receptors in pigs. Immunogenetics 2009;61:153–160.
214
Luo R, Xiao S, Jiang Y, et al. Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses interferon-beta production by interfering with the RIG-I signaling pathway. Mol Immunol 2008;45:2839–2846.
215
Tohno M, Shimazu T, Aso H, et al. Molecular cloning and functional characterization of porcine nucleotide-binding oligomerization domain-1 (NOD1) recognizing minimum agonists, meso-diaminopimelic acid and meso-lanthionine. Mol Immunol 2008;45:1807–1817.
216
Tohno M, Ueda W, Azuma Y, et al. Molecular cloning and functional characterization of porcine nucleotide-binding oligomerization domain-2 (NOD2). Mol Immunol 2008;45:194–203.
217
Tohno M, Shimazu T, Aso H, et al. Molecular cloning and functional characterization of porcine MyD88 essential for TLR signaling. Cell Mol Immunol 2007;4:369–376.
218
Kwon S, Gewirtz AT, Hurley DJ, et al. Disparities in TLR5 expression and responsiveness to flagellin in equine neutrophils and mononuclear phagocytes. J Immunol 2011;186:6263–6270.
219
Gold JR, Perkins GA, Erb HN, et al. Cytokine profiles of peripheral blood mononuclear cells isolated from septic and healthy neonatal foals. J Vet Intern Med 2007;21:482–488.
Direct Link:
220
Lopes MA, Salter CE, Vandenplas ML, et al. Expression of inflammation-associated genes in circulating leukocytes collected from horses with gastrointestinal tract disease. Am J Vet Res 2010;71:915–924.
221
Menzies-Gow NJ, Bailey SR, Stevens K, et al. Digital blood flow and plasma endothelin concentration in clinically endotoxemic horses. Am J Vet Res 2005;66:630–636.
222
Figueiredo MD, Vandenplas ML, Hurley DJ, et al. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Vet Immunol Immunopathol 2009;127:125–134.
223
Allenspach K, House A, Smith K, et al. Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German Shepherd Dogs with chronic enteropathies. Vet Microbiol 2010;146:326–335.
224
Tian X, Pascal G, Monget P. Evolution and functional divergence of NLRP genes in mammalian reproductive systems. BMC Evol Biol 2009;9:202.
225
Burgener IA, Jungi TW. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet Immunol Immunopathol 2008;124:184–191.
226
Chotimanukul S, Sirivaidyapong S. Differential expression of Toll-like receptor 4 (TLR4) in healthy and infected canine endometrium. Theriogenology 2011;76:1152–1161.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
227
Abujamra AL, Spanjaard RA, Akinsheye I, et al. Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism. Virology 2006;345:390–403.
228
Burgener IA, Konig A, Allenspach K, et al. Upregulation of Toll-like receptors in chronic enteropathies in dogs. J Vet Intern Med 2008;22:553–560.
Direct Link:
229
House AK, Binns MM, Gregory SP, et al. Analysis of NOD1, NOD2, TLR1, TLR2, TLR4, TLR5, TLR6 and TLR9 genes in anal furunculosis of German Shepherd Dogs. Tissue Antigens 2009;73:250–254.
Direct Link:
230
Kathrani A, House A, Catchpole B, et al. Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German Shepherd Dogs. PLoS ONE 2010;5:e15740.
231
Kathrani A, House A, Catchpole B, et al. Breed-independent Toll-like receptor 5 polymorphisms show association with canine inflammatory bowel disease. Tissue Antigens 2011;78:94–101.
Direct Link:
232
Mikula I, Bhide M, Pastorekova S. Characterization of ovine TLR7 and TLR8 protein coding regions, detection of mutations and Maedi Visna virus infection. Vet Immunol Immunopathol 2010;138:51–59.
233
McCullough KC, Summerfield A. Targeting the porcine immune system–particulate vaccines in the 21st century. Dev Comp Immunol 2009;33:394–409.
234
Li J, Birkenheuer AJ, Marr HS, et al. Expression and function of triggering receptor expressed on myeloid cells-1 (TREM-1) on canine neutrophils. Dev Comp Immunol 2011;35:872–880.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
235
Derive M, Massin F, Gibot S. Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases. Self Nonself 2010;1:225–230.
- PubMed
236
Zhu J, Mohan C. Toll-like receptor signaling pathways–therapeutic opportunities. Mediators Inflamm 2010;2010:781235.
237
Yamamoto M, Takeda K. Current views of Toll-like receptor signaling pathways. Gastroenterol Res Pract 2010;2010:240365.
- PubMed
238
Lin Q, Li M, Fang D, et al. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases. Int Immunopharmacol 2011;11:1422–1432.
239
Damas P, Reuter A, Gysen P, et al. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989;17:975–978.
240
Girardin E, Grau GE, Dayer JM, et al. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988;319:397–400.
241
Basoglu A, Sen I, Sevinc M, et al. Serum concentrations of tumor necrosis factor-alpha in neonatal calves with presumed septicemia. J Vet Intern Med 2004;18:238–241.
- PubMed,
- Web of Science® Times Cited: 4
242
Otto CM, Drobatz KJ, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997;11:65–70.
Direct Link:
243
Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008;214:149–160.
Direct Link:
244
Naude PJ, den Boer JA, Luiten PG, et al. Tumor necrosis factor receptor cross-talk. FEBS J 2011;278:888–898.
Direct Link:
245
Vinay DS, Kwon BS. The tumour necrosis factor/TNF receptor superfamily: Therapeutic targets in autoimmune diseases. Clin Exp Immunol 2011;164:145–157.
Direct Link:
246
Micheau O, Lens S, Gaide O, et al. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001;21:5299–5305.
247
Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993;268:18542–18548.
248
Mark KS, Trickler WJ, Miller DW. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol Exp Ther 2001;297:1051–1058.
249
Pober JS, Bevilacqua MP, Mendrick DL, et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986;136:1680–1687.
250
Munro JM, Pober JS, Cotran RS. Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol 1989;135:121–133.
251
Sakaue Y, Nezu Y, Yanagisawa S, et al. Effects of continuous low-dose infusion of lipopolysaccharide on expression of E-selectin and intercellular adhesion molecule-1 messenger RNA and neutrophil accumulation in specific organs in dogs. Am J Vet Res 2005;66:1259–1266.
252
Miyamoto T, Fujinaga T, Yamashita K, et al. Changes of serum cytokine activities and other parameters in dogs with experimentally induced endotoxic shock. Jpn J Vet Res 1996;44:107–118.
- PubMed,
- CAS
253
LeMay DR, LeMay LG, Kluger MJ, et al. Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am J Physiol 1990;259:R126–132.
254
Otto CM, Rawlings CA. Tumor necrosis factor production in cats in response to lipopolysaccharide: An in vivo and in vitro study. Vet Immunol Immunopathol 1995;49:183–188.
255
MacKay RJ, Merritt AM, Zertuche JM, et al. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am J Vet Res 1991;52:533–538.
256
Nieto JE, MacDonald MH, Braim AE, et al. Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo. Equine Vet J 2009;41:717–719.
Direct Link:
257
MacKay RJ, Lester GD. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin. Am J Vet Res 1992;53:1285–1289.
258
Huang H, Lavoie-Lamoureux A, Moran K, et al. IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2007;292:L1147–1154.
259
Barton MH, Collatos C. Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J Vet Intern Med 1999;13:457–464.
Direct Link:
260
Stich AN, DeClue AE. Pathogen associated molecular pattern-induced TNF, IL-1beta, IL-6 and CXCL-8 production from feline whole blood culture. Res Vet Sci 2011;90:59–63.
261
Osterbur K, Whitehead Z, Sharp CR, et al. Plasma nitrate/nitrite concentrations in dogs with naturally developing sepsis and non-infectious forms of the systemic inflammatory response syndrome. Vet Rec 2011;169:554.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
262
LeBlanc CJ, Horohov DW, Bauer JE, et al. Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs. Am J Vet Res 2008;69:486–493.
263
Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986;83:4533–4537.
264
Cartwright N, McMaster SK, Sorrentino R, et al. Elucidation of Toll-like receptor and adapter protein signaling in vascular dysfunction induced by gram-positive Staphylococcus aureus or gram-negative Escherichia coli. Shock 2007;27:40–47.
265
Jimenez R, Belcher E, Sriskandan S, et al. Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc Natl Acad Sci USA 2005;102:4637–4642.
266
Schouten M, Wiersinga WJ, Levi M, et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008;83:536–545.
267
Cavaillon JM, Adib-Conquy M, Fitting C, et al. Cytokine cascade in sepsis. Scand J Infect Dis 2003;35:535–544.
268
Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997;112:321S–329S.
269
Stylianou E, Saklatvala J. Interleukin-1. Int J Biochem Cell Biol 1998;30:1075–1079.
270
Chaitanya GV, Franks SE, Cromer W, et al. Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. Lymphat Res Biol 2010;8:155–164.
271
Dinarello CA. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol 2011;41:1203–1217.
Direct Link:
272
Jawa RS, Anillo S, Huntoon K, et al. Analytic review: Interleukin-6 in surgery, trauma, and critical care: Part I: Basic science. J Intensive Care Med 2011;26:3–12.
- CrossRef,
- PubMed
273
Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011;1813:878–888.
274
Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996;24:392–397.
275
Remick DG, Bolgos GR, Siddiqui J, et al. Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002;17:463–467.
276
Burton AB, Wagner B, Erb HN, et al. Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals. Vet Immunol Immunopathol 2009;132:122–128.
277
Scumpia PO, Moldawer LL. Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med 2005;33:S468–S471.
278
Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002;30:S58–S63.
279
Seitz M, Loetscher P, Dewald B, et al. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 1995;25:1129–1132.
Direct Link:
280
Kusske AM, Rongione AJ, Ashley SW, et al. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996;120:284–288; discussion 289.
281
Briassoulis G, Venkataraman S, Thompson A. Cytokines and metabolic patterns in pediatric patients with critical illness. Clin Dev Immunol 2010;2010:354047.
282
Pusterla N, Magdesian KG, Mapes S, et al. Expression of molecular markers in blood of neonatal foals with sepsis. Am J Vet Res 2006;67:1045–1049.
283
Kipar A, Meli ML, Failing K, et al. Natural feline coronavirus infection: Differences in cytokine patterns in association with the outcome of infection. Vet Immunol Immunopathol 2006;112:141–155.
284
Gao L, Flores C, Fan-Ma S, et al. Macrophage migration inhibitory factor in acute lung injury: Expression, biomarker, and associations. Transl Res 2007;150:18–29.
285
Calandra T, Roger T. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 2003;3:791–800.
286
Bozza M, Satoskar AR, Lin G, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999;189:341–346.
287
Brenner T, Hofer S, Rosenhagen C, et al. Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock. J Surg Res 2010;164:e163–171.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
288
Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002;99:345–350.
289
Stros M. HMGB proteins: Interactions with DNA and chromatin. Biochim Biophys Acta 2010;1799:101–113.
290
Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta 2010;1799:149–156.
291
van Zoelen MA, Yang H, Florquin S, et al. Role of Toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 2009;31:280–284.
292
Huang W, Tang Y, Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 2010;51:119–126.
293
Mitola S, Belleri M, Urbinati C, et al. Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 2006;176:12–15.
294
Yu DH, Nho DH, Song RH, et al. High-mobility group box 1 as a surrogate prognostic marker in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) 2010;20:298–302.
Direct Link:
295
Karlsson S, Pettila V, Tenhunen J, et al. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med 2008;34:1046–1053.
296
de Jong HK, van der Poll T, Wiersinga WJ. The systemic pro-inflammatory response in sepsis. J Innate Immun 2010;2:422–430.
297
Cray C, Zaias J, Altman NH. Acute phase response in animals: A review. Comp Med 2009;59:517–526.
298
Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–266.
Direct Link:
299
Gruys E, Toussaint MJ, Niewold TA, et al. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005;6:1045–1056.
- CrossRef,
- PubMed,
- CAS
300
Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: The acute-phase proteins. Protein Pept Lett 2002;9:211–223.
301
Noursadeghi M, Pepys MB, Gallimore R, et al. Relationship of granulocyte colony stimulating factor with other acute phase reactants in man. Clin Exp Immunol 2005;140:97–100.
Direct Link:
302
Ceron JJ, Eckersall PD, Martynez-Subiela S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Vet Clin Pathol 2005;34:85–99.
Direct Link:
303
Eckersall PD, Bell R. Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine. Vet J 2010;185:23–27.
304
Kjelgaard-Hansen M, Jacobsen S. Assay validation and diagnostic applications of major acute-phase protein testing in companion animals. Clin Lab Med 2011;31:51–70.
305
Tvarijonaviciute A, Eralp O, Kocaturk M, et al. Adiponectin and IGF-1 are negative acute phase proteins in a dog model of acute endotoxaemia. Vet Immunol Immunopathol 2011;140:147–151.
306
Castelli GP, Pognani C, Meisner M, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:R234–R242.
307
Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396–402.
308
Kuzi S, Aroch I, Peleg K, et al. Canine procalcitonin messenger RNA expression. J Vet Diagn Invest 2008;20:629–633.
309
Giunti M, Peli A, Battilani M, et al. Evaluation of CALC-I gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) 2010;20:523–527.
Direct Link:
310
Mukorera V, Dvir E, van der Merwe LL, et al. Serum C-reactive protein concentration in benign and malignant canine spirocercosis. J Vet Intern Med 2011;25:963–966.
Direct Link:
311
Koster LS, Van Schoor M, Goddard A, et al. C-reactive protein in canine babesiosis caused by Babesia rossi and its association with outcome. J S Afr Vet Assoc 2009;80:87–91.
312
Sheahan D, Bell R, Mellanby RJ, et al. Acute phase protein concentrations in dogs with nasal disease. Vet Rec 2010;167:895–899.
313
Lowrie M, Penderis J, Eckersall PD, et al. The role of acute phase proteins in diagnosis and management of steroid-responsive meningitis arteritis in dogs. Vet J 2009;182:125–130.
314
Griebsch C, Arndt G, Raila J, et al. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia. Vet Clin Pathol 2009;38:421–425.
Direct Link:
315
Mitchell KD, Kruth SA, Wood RD, et al. Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia. J Vet Intern Med 2009;23:585–591.
Direct Link:
316
Bathen-Noethen A, Carlson R, Menzel D, et al. Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis. J Vet Intern Med 2008;22:1149–1156.
Direct Link:
317
Nakamura M, Takahashi M, Ohno K, et al. C-reactive protein concentration in dogs with various diseases. J Vet Med Sci 2008;70:127–131.
318
Ohno K, Yokoyama Y, Nakashima K, et al. C-reactive protein concentration in canine idiopathic polyarthritis. J Vet Med Sci 2006;68:1275–1279.
319
Dabrowski R, Wawron W, Kostro K. Changes in CRP, SAA and haptoglobin produced in response to ovariohysterectomy in healthy bitches and those with pyometra. Theriogenology 2007;67:321–327.
320
Planellas M, Bassols A, Siracusa C, et al. Evaluation of serum haptoglobin and C-reactive protein in dogs with mammary tumors. Vet Clin Pathol 2009;38:348–352.
Direct Link:
321
Nielsen L, Toft N, Eckersall PD, et al. Serum C-reactive protein concentration as an indicator of remission status in dogs with multicentric lymphoma. J Vet Intern Med 2007;21:1231–1236.
Direct Link:
322
Caldin M, Tasca S, Carli E, et al. Serum acute phase protein concentrations in dogs with hyperadrenocorticism with and without concurrent inflammatory conditions. Vet Clin Pathol 2009;38:63–68.
Direct Link:
323
Chan DL, Rozanski EA, Freeman LM. Relationship among plasma amino acids, C-reactive protein, illness severity, and outcome in critically ill dogs. J Vet Intern Med 2009;23:559–563.
Direct Link:
324
Gebhardt C, Hirschberger J, Rau S, et al. Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care (San Antonio) 2009;19:450–458.
Direct Link:
325
van der Poll T, de Boer JD, Levi M. The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis 2011;24:273–278.
326
Machado FR, Cesar MS. Sepsis, coagulation and anticoagulants. Endocr Metab Immune Disord Drug Targets 2010;10:204–213.
- PubMed,
- CAS
327
Sun H. The interaction between pathogens and the host coagulation system. Physiology (Bethesda) 2006;21:281–288.
328
Huisse MG, Pease S, Hurtado-Nedelec M, et al. Leukocyte activation: The link between inflammation and coagulation during heatstroke. A study of patients during the 2003 heat wave in Paris. Crit Care Med 2008;36:2288–2295.
329
de Laforcade AM, Freeman LM, Shaw SP, et al. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003;17:674–679.
330
Bentz AI, Palmer JE, Dallap BL, et al. Prospective evaluation of coagulation in critically ill neonatal foals. J Vet Intern Med 2009;23:161–167.
Direct Link:
331
Estrin MA, Wehausen CE, Jessen CR, et al. Disseminated intravascular coagulation in cats. J Vet Intern Med 2006;20:1334–1339.
Direct Link:
332
Norris CR, Griffey SM, Samii VF. Pulmonary thromboembolism in cats: 29 cases (1987-1997). J Am Vet Med Assoc 1999;215:1650–1654.
333
Lucas WE, Kitzmiller JL. The role of intravascular coagulation in feline endotoxin shock. Surg Gynecol Obstet 1972;134:73–77.
334
DeClue AE, Williams KJ, Sharp C, et al. Systemic response to low-dose endotoxin infusion in cats. Vet Immunol Immunopathol 2009;132:167–174.
335
DelGiudice LA, White GA. The role of tissue factor and tissue factor pathway inhibitor in health and disease states. J Vet Emerg Crit Care (San Antonio) 2009;19:23–29.
Direct Link:
336
Dallap Schaer BL, Epstein K. Coagulopathy of the critically ill equine patient. J Vet Emerg Crit Care (San Antonio) 2009;19:53–65.
Direct Link:
337
Hopper K, Bateman S. An updated view of hemostasis: Mechanisms of hemostatic dysfuntion associated with sepsis. J Vet Emerg Crit Car 2005;15:83–91.
Direct Link:
338
Pawlinski R, Mackman N. Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res 2010;125(Suppl 1):S70–S73.
339
Stokol T, Daddona JL, Choi B. Evaluation of tissue factor procoagulant activity on the surface of feline leukocytes in response to treatment with lipopolysaccharide and heat-inactivated fetal bovine serum. Am J Vet Res 2010;71:623–629.
340
Grunig G, Hulliger C, Winder C, et al. Spontaneous and lipopolysaccharide-induced expression of procoagulant activity by equine lung macrophages in comparison with blood monocytes and blood neutrophils. Vet Immunol Immunopathol 1991;29:295–312.
341
Ouellette AL, Evans RJ, Heath MF. Platelets enhance endotoxin-induced monocyte tissue factor (TF) activity in the horse. Res Vet Sci 2004;76:31–35.
342
Henry MM, Moore JN. Clinical relevance of monocyte procoagulant activity in horses with colic. J Am Vet Med Assoc 1991;198:843–848.
343
Aras O, Shet A, Bach RR, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004;103:4545–4553.
344
Soriano AO, Jy W, Chirinos JA, et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 2005;33:2540–2546.
345
Meziani F, Delabranche X, Asfar P, et al. Bench-to-bedside review: Circulating microparticles–a new player in sepsis? Crit Care 2010;14:236.
346
Miyoshi T, Yamashita K, Arai T, et al. The role of endothelial interleukin-8/NADPH oxidase 1 axis in sepsis. Immunology 2010;131:331–339.
Direct Link:
347
Pawlinski R, Pedersen B, Schabbauer G, et al. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004;103:1342–1347.
348
Rogers CL, Rozanski EA. Von Willebrand factor antigen concentration in dogs with sepsis. J Vet Intern Med 2010;24:229–230.
Direct Link:
349
Pantaleon LG, Furr MO, McKenzie HC, et al. Effects of small- and large-volume resuscitation on coagulation and electrolytes during experimental endotoxemia in anesthetized horses. J Vet Intern Med 2007;21:1374–1379.
- PubMed,
- Web of Science® Times Cited: 5
350
Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709.
351
Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med 2007;204:2439–2448.
352
Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536–555.
353
Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327.
354
Marti-Carvajal AJ, Sola I, Lathyris D, et al. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev 2011;4:CD004388.
- PubMed
355
Jackson CV, Bailey BD, Shetler TJ. Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis. J Pharmacol Exp Ther 2000;295:967–971.
356
Burdick MD, Schaub RG. Human protein C induces anticoagulation and increased fibrinolytic activity in the cat. Thromb Res 1987;45:413–419.
357
Oehmcke S, Herwald H. Contact system activation in severe infectious diseases. J Mol Med (Berl) 2010;88:121–126.
358
Frick IM, Bjorck L, Herwald H. The dual role of the contact system in bacterial infectious disease. Thromb Haemost 2007;98:497–502.
359
Kaplan AP, Ghebrehiwet B. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol 2010;47:2161–2169.
360
Yarovaya GA, Blokhina TB, Neshkova EA. Contact system. New concepts on activation mechanisms and bioregulatory functions. Biochemistry (Mosc) 2002;67:13–24.
361
Rojkjaer R, Schmaier AH. Activation of the plasma kallikrein/kinin system on endothelial cell membranes. Immunopharmacology 1999;43:109–114.
362
Dong JF. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost 2005;3:1710–1716.
Direct Link:
363
Claus RA, Bockmeyer CL, Sossdorf M, et al. The balance between von Willebrand factor and its cleaving protease ADAMTS13: Biomarker in systemic inflammation and development of organ failure? Curr Mol Med 2010;10:236–248.
364
Kremer Hovinga JA, Zeerleder S, Kessler P, et al. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 2007;5:2284–2290.
Direct Link:
365
Martin K, Borgel D, Lerolle N, et al. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 2007;35:2375–2382.
366
Ono T, Mimuro J, Madoiwa S, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation with development of renal failure. Blood 2006;107:528–534.
367
Adib-Conquy M, Cavaillon JM. Compensatory anti-inflammatory response syndrome. Thromb Haemost 2009;101:36–47.
368
Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125–1128.
369
Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 2008;29:617–625, viii.
370
Osuchowski MF, Welch K, Siddiqui J, et al. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006;177:1967–1974.
371
Mokart D, Capo C, Blache JL, et al. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002;89:1450–1456.
Direct Link:
372
Mokart D, Merlin M, Sannini A, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): Early markers of postoperative sepsis after major surgery. Br J Anaesth 2005;94:767–773.
373
Neunaber C, Zeckey C, Andruszkow H, et al. Immunomodulation in polytrauma and polymicrobial sepsis: Where do we stand? Recent Pat Inflamm Allergy Drug Discov 2011;5:17–25.
- CrossRef,
- PubMed,
- CAS
374
Power C, Fanning N, Redmond HP. Cellular apoptosis and organ injury in sepsis: A review. Shock 2002;18:197–211.
375
Ward PA. Sepsis, apoptosis and complement. Biochem Pharmacol 2008;76:1383–1388.
376
Paula Neto HA, Kubes P. Platelets, endothelium and shear join forces to mislead neutrophils in sepsis. Crit Care 2011;15:103.
377
Alves-Filho JC, Spiller F, Cunha FQ. Neutrophil paralysis in sepsis. Shock 2010;34(Suppl 1):15–21.
378
Delano MJ, Thayer T, Gabrilovich S, et al. Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J Immunol 2011;186:195–202.
379
Ocuin LM, Bamboat ZM, Balachandran VP, et al. Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. J Leukoc Biol 2011;89:423–432.
380
Escoll P, del Fresno C, Garcia L, et al. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 2003;311:465–472.
381
Wullaert A, Verstrepen L, Van Huffel S, et al. LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation. J Biol Chem 2007;282:81–90.
382
Wolk K, Docke WD, von Baehr V, et al. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000;96:218–223.
383
Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 1997;3:678–681.
384
Tschaikowsky K, Hedwig-Geissing M, Schiele A, et al. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002;30:1015–1023.
385
Wesche DE, Lomas-Neira JL, Perl M, et al. Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 2005;78:325–337.
386
Hsieh YC, Athar M, Chaudry IH. When apoptosis meets autophagy: Deciding cell fate after trauma and sepsis. Trends Mol Med 2009;15:129–138.
387
Pinheiro da Silva F, Nizet V. Cell death during sepsis: Integration of disintegration in the inflammatory response to overwhelming infection. Apoptosis 2009;14:509–521.
388
Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011;469:323–335.
389
Giansanti V, Torriglia A, Scovassi AI. Conversation between apoptosis and autophagy: “Is it your turn or mine?”. Apoptosis 2011;16:321–333.
390
Watanabe E, Muenzer JT, Hawkins WG, et al. Sepsis induces extensive autophagic vacuolization in hepatocytes: A clinical and laboratory-based study. Lab Invest 2009;89:549–561.
391
Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol 2009;7:99–109.
392
Kepp O, Galluzzi L, Zitvogel L, et al. Pyroptosis ‒ A cell death modality of its kind? Eur J Immunol 2010;40:627–630.
Direct Link:
393
Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005;73:1907–1916.
394
Shao W, Yeretssian G, Doiron K, et al. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem 2007;282:36321–36329.
395
Nakajima Y, Mikami O, Yoshioka M, et al. Involvement of apoptosis in the endotoxemic lesions of the liver and kidneys of piglets. J Vet Med Sci 2000;62:621–626.
396
Sato M, Mikami O, Kobayashi M, et al. Apoptosis in the lymphatic organs of piglets inoculated with classical swine fever virus. Vet Microbiol 2000;75:1–9.
397
Messmer UK, Briner VA, Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 1999;55:2322–2337.
398
Messmer UK, Winkel G, Briner VA, et al. Glucocorticoids potently block tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptotic cell death in bovine glomerular endothelial cells upstream of caspase 3 activation. Br J Pharmacol 1999;127:1633–1640.
Direct Link:
399
Sylte MJ, Leite FP, Kuckleburg CJ, et al. Caspase activation during Haemophilus somnus lipooligosaccharide-mediated apoptosis of bovine endothelial cells. Microb Pathog 2003;35:285–291.
400
Kuckleburg CJ, Tiwari R, Czuprynski CJ. Endothelial cell apoptosis induced by bacteria-activated platelets requires caspase-8 and -9 and generation of reactive oxygen species. Thromb Haemost 2008;99:363–372.
401
Wohlschlaeger J, Stubbe HD, Schmitz KJ, et al. Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model. Pathol Res Pract 2005;201:809–817.
402
Umeshappa CS, Singh KP, Nanjundappa RH, et al. Apoptosis and immuno-suppression in sheep infected with bluetongue virus serotype-23. Vet Microbiol 2010;144:310–318.
403
Crouser ED, Julian MW, Weinstein DM, et al. Endotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated. Am J Respir Crit Care Med 2000;161:1705–1712.
404
Paillot R, Richard S, Bloas F, et al. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders. Vet Immunol Immunopathol 2005;106:1–14.
405
Rahal L, Garrido AG, Cruz RJ Jr, et al. Fluid replacement with hypertonic or isotonic solutions guided by mixed venous oxygen saturation in experimental hypodynamic sepsis. J Trauma 2009;67:1205–1212.
406
Collins AM, Sewell WA, Edwards MR. Immunoglobulin gene rearrangement, repertoire diversity, and the allergic response. Pharmacol Ther 2003;100:157–170.
407
Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol 2004;4:123–132.
408
Hollander GA, Peterson P. Learning to be tolerant: How T cells keep out of trouble. J Intern Med 2009;265:541–561.
Direct Link:
409
McCaughtry TM, Hogquist KA. Central tolerance: What have we learned from mice? Semin Immunopathol 2008;30:399–409.
410
Parish IA, Heath WR. Too dangerous to ignore: Self-tolerance and the control of ignorant autoreactive T cells. Immunol Cell Biol 2008;86:146–152.
411
Waldmann H. Tolerance: An overview and perspectives. Nat Rev Nephrol 2010;6:569–576.
412
Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol 2010;11:21–27.
413
Miyara M, Sakaguchi S. Human FoxP3⁺CD4⁺ regulatory T cells: Their knowns and unknowns. Immunol Cell Biol 2011;89:346–351.
414
Sakaguchi S. Regulatory T cells: History and perspective. Methods Mol Biol 2011;707:3–17.
415
Shevach EM. The resurrection of T cell-mediated suppression. J Immunol 2011;186:3805–3807.
416
Garden OA, Pinheiro D, Cunningham F. All creatures great and small: Regulatory T cells in mice, humans, dogs and other domestic animal species. Int Immunopharmacol 2011;11:576–588.
417
Lankford S, Petty C, LaVoy A, et al. Cloning of feline FOXP3 and detection of expression in CD4⁺ CD25⁺ regulatory T cells. Vet Immunol Immunopathol 2008;122:159–166.
418
Petty CS, Tompkins MB, Tompkins WA. Transforming growth factor-beta/transforming growth factor-betaRII signaling may regulate CD4⁺CD25⁺ T-regulatory cell homeostasis and suppressor function in feline AIDS lentivirus infection. J Acquir Immune Defic Syndr 2008;47:148–160.
419
Smithberg SR, Fogle JE, Mexas AM, et al. In vivo depletion of CD4⁺CD25⁺ regulatory T cells in cats. J Immunol Methods 2008;329:81–91.
420
Vahlenkamp TW, Tompkins MB, Tompkins WA. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4⁺CD25⁺ T regulatory cells. J Immunol 2004;172:4752–4761.
421
Fogle JE, Tompkins WA, Tompkins MB. CD4⁺ CD25⁺ T regulatory cells from FIV⁺ cats induce a unique anergic profile in CD8⁺ lymphocyte targets. Retrovirology 2010;7:97.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
422
Fogle JE, Mexas AM, Tompkins WA, et al. CD4⁺CD25⁺ T regulatory cells inhibit CD8⁺ IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism. AIDS Res Hum Retroviruses 2010;26:201–216.
423
Achleitner A, Clark ME, Bienzle D. T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1). Vet Immunol Immunopathol 2011;143:307–313.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
424
Biller BJ, Elmslie RE, Burnett RC, et al. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol 2007;116:69–78.
425
Keppel KE, Campbell KL, Zuckermann FA, et al. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Vet Immunol Immunopathol 2008;123:337–344.
426
O'Neill K, Guth A, Biller B, et al. Changes in regulatory T cells in dogs with cancer and associations with tumor type. J Vet Intern Med 2009;23:875–881.
Direct Link:
427
Horiuchi Y, Tominaga M, Ichikawa M, et al. Increase of regulatory T cells in the peripheral blood of dogs with metastatic tumors. Microbiol Immunol 2009;53:468–474.
Direct Link:
428
Mizuno T, Suzuki R, Umeki S, et al. Crossreactivity of antibodies to canine CD25 and Foxp3 and identification of canine CD4⁺CD25⁺Foxp3⁺ cells in canine peripheral blood. J Vet Med Sci 2009;71:1561–1568.
429
Abrams VK, Hwang B, Lesnikova M, et al. A novel monoclonal antibody specific for canine CD25 (P4A10): Selection and evaluation of canine Tregs. Vet Immunol Immunopathol 2010;135:257–265.
430
Rissetto KC, Rindt H, Selting KA, et al. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma. Vet Immunol Immunopathol 2010;135:137–145.
431
Horiuchi Y, Tominaga M, Ichikawa M, et al. Relationship between regulatory and type 1 T cells in dogs with oral malignant melanoma. Microbiol Immunol 2010;54:152–159.
Direct Link:
432
Pinheiro D, Singh Y, Grant CR, et al. Phenotypic and functional characterization of a CD4⁺ CD25^high FOXP3^high regulatory T-cell population in the dog. Immunology 2011;132:111–122.
Direct Link:
433
Burton JH, Mitchell L, Thamm DH, et al. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. J Vet Intern Med 2011;25:920–926.
Direct Link:
434
Kaser T, Gerner W, Hammer SE, et al. Detection of Foxp3 protein expression in porcine T lymphocytes. Vet Immunol Immunopathol 2008;125:92–101.
435
Kaser T, Gerner W, Hammer SE, et al. Phenotypic and functional characterisation of porcine CD4⁺CD25^high regulatory T cells. Vet Immunol Immunopathol 2008;122:153–158.
436
Bolzer K, Kaser T, Saalmuller A, et al. Molecular characterisation of porcine Forkhead-box p3 (Foxp3). Vet Immunol Immunopathol 2009;132:275–281.
437
Wongyanin P, Buranapraditkun S, Chokeshai-Usaha K, et al. Induction of inducible CD4⁺CD25⁺Foxp3⁺ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV). Vet Immunol Immunopathol 2010;133:170–182.
438
Silva-Campa E, Flores-Mendoza L, Resendiz M, et al. Induction of T helper 3 regulatory cells by dendritic cells infected with porcine reproductive and respiratory syndrome virus. Virology 2009;387:373–379.
439
Dawson H, Solano-Aguilar G, Beal M, et al. Localized Th1-, Th2-, T regulatory cell-, and inflammation-associated hepatic and pulmonary immune responses in Ascaris suum-infected swine are increased by retinoic acid. Infect Immun 2009;77:2576–2587.
440
Pilon C, Meurens F, Dauba A, et al. Induction of porcine regulatory cells by mycophenolic acid-treated dendritic cells. Transplant Proc 2009;41:700–702.
441
Kaser T, Gerner W, Mair K, et al. Current knowledge on porcine regulatory T cells. Vet Immunol Immunopathol 2011;http://doi.org/10.1016/j.vetimm.2011.05.035 (in press).
- CrossRef,
- PubMed
442
Kaser T, Gerner W, Saalmuller A. Porcine regulatory T cells: Mechanisms and T-cell targets of suppression. Dev Comp Immunol 2011;35:1166–1172.
443
Gerner W, Stadler M, Hammer SE, et al. Sensitive detection of Foxp3 expression in bovine lymphocytes by flow cytometry. Vet Immunol Immunopathol 2010;138:154–158.
444
Hoek A, Rutten VP, Kool J, et al. Subpopulations of bovine WC1⁺ gammadelta T cells rather than CD4⁺CD25^high Foxp3⁺ T cells act as immune regulatory cells ex vivo. Vet Res 2009;40:6.
445
Seo KS, Davis WC, Hamilton MJ, et al. Development of monoclonal antibodies to detect bovine FOXP3 in PBMCs exposed to a staphylococcal superantigen. Vet Immunol Immunopathol 2009;128:30–36.
446
de Almeida DE, Colvin CJ, Coussens PM. Antigen-specific regulatory T cells in bovine paratuberculosis. Vet Immunol Immunopathol 2008;125:234–245.
447
McNeilly TN, McIntyre J, Frew D, et al. Infestation of sheep with Psoroptes ovis, the sheep scab mite, results in recruitment of Foxp3(+) T cells into the dermis. Parasite Immunol 2010;32:361–369.
Direct Link:
448
Rocchi MS, Wattegedera SR, Frew D, et al. Identification of CD4(+)CD25(high) Foxp3(+) T cells in ovine peripheral blood. Vet Immunol Immunopathol 2011;144:172–177.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
449
Wagner B, Hillegas JM, Brinker DR, et al. Characterization of monoclonal antibodies to equine interleukin-10 and detection of T regulatory 1 cells in horses. Vet Immunol Immunopathol 2008;122:57–64.
450
Hamza E, Torsteinsdottir S, Eydal M, et al. Increased IL-4 and decreased regulatory cytokine production following relocation of Icelandic horses from a high to low endoparasite environment. Vet Immunol Immunopathol 2010;133:40–50.
451
Hamza E, Steinbach F, Marti E. CD4⁺CD25⁺ T cells expressing FoxP3 in Icelandic horses affected with insect bite hypersensitivity. Vet Immunol Immunopathol 2011;http://doi.org/10.1016/j.vetimm.2011.05.033 (in press).
- CrossRef,
- PubMed
452
Wagner B, Burton A, Ainsworth D. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet Res 2010;41:47.
453
Heimann M, Janda J, Sigurdardottir OG, et al. Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: A possible role for regulatory T cells. Vet Immunol Immunopathol 2011;140:63–74.
454
Robbin MG, Wagner B, Noronha LE, et al. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers. Vet Immunol Immunopathol 2011;140:90–101.
455
Langier S, Sade K, Kivity S. Regulatory T cells: The suppressor arm of the immune system. Autoimmun Rev 2010;10:112–115.
456
Sakaguchi S, Wing K, Onishi Y, et al. Regulatory T cells: How do they suppress immune responses? Int Immunol 2009;21:1105–1111.
457
Workman CJ, Szymczak-Workman AL, Collison LW, et al. The development and function of regulatory T cells. Cell Mol Life Sci 2009;66:2603–2622.
458
Rudensky AY. Regulatory T cells and Foxp3. Immunol Rev 2011;241:260–268.
Direct Link:
459
Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 2007;7:305–310.
460
Shalev I, Schmelzle M, Robson SC, et al. Making sense of regulatory T cell suppressive function. Semin Immunol 2011;23:282–292.
461
Wan YY. Regulatory T cells: Immune suppression and beyond. Cell Mol Immunol 2010;7:204–210.
462
Caramalho I, Lopes-Carvalho T, Ostler D, et al. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403–411.
463
Dai J, Liu B, Li Z. Regulatory T cells and Toll-like receptors: What is the missing link? Int Immunopharmacol 2009;9:528–533.
464
Liu H, Komai-Koma M, Xu D, et al. Toll-like receptor 2 signaling modulates the functions of CD4⁺CD25⁺ regulatory T cells. Proc Natl Acad Sci USA 2006;103:7048–7053.
465
Nyirenda MH, O'Brien K, Sanvito L, et al. Modulation of regulatory T cells in health and disease: Role of toll-like receptors. Inflamm Allergy Drug Targets 2009;8:124–129.
- CrossRef,
- PubMed,
- CAS
466
Monneret G, Debard AL, Venet F, et al. Marked elevation of human circulating CD4⁺ CD25⁺ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003;31:2068–2071.
467
Saito K, Wagatsuma T, Toyama H, et al. Sepsis is characterized by the increases in percentages of circulating CD4⁺ CD25⁺ regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med 2008;216:61–68.
468
Venet F, Chung CS, Kherouf H, et al. Increased circulating regulatory T cells (CD4⁺CD25⁺CD127^-) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009;35:678–686.
469
Venet F, Pachot A, Debard AL, et al. Increased percentage of CD4⁺ CD25⁺ regulatory T cells during septic shock is due to the decrease of CD4⁺CD25- lymphocytes. Crit Care Med 2004;32:2329–2331.
- PubMed,
- Web of Science® Times Cited: 51
470
Heuer JG, Zhang T, Zhao J, et al. Adoptive transfer of in vitro-stimulated CD4⁺ CD25⁺ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 2005;174:7141–7146.
471
Scumpia PO, Delano MJ, Kelly KM, et al. Increased natural CD4⁺ CD25⁺ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 2006;177:7943–7949.
472
Wisnoski N, Chung CS, Chen Y, et al. The contribution of CD4⁺ CD25⁺ T-regulatory-cells to immune suppression in sepsis. Shock 2007;27:251–257.
473
Tiemessen MM, Jagger AL, Evans HG, et al. CD4⁺ CD25⁺ Foxp3⁺ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 2007;104:19446–19451.
474
Venet F, Pachot A, Debard AL, et al. Human CD4⁺ CD25⁺ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 2006;177:6540–6547.
475
Hodge G, Scott J, Osborn M, et al. Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients. Cytokine 2011;53:286–288.
- CrossRef,
- PubMed,
- CAS,
- Web of Science®
476
Huang LF, Yao YM, Dong N, et al. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Crit Care 2010;14:R3.
477
Hein F, Massin F, Cravoisy-Popovic A, et al. The relationship between CD4⁺ CD25⁺CD127- regulatory T cells and inflammatory response and outcome during shock states. Crit Care 2010;14:R19.
478
van Maren WW, Jacobs JF, de Vries IJ, et al. Toll-like receptor signalling on Tregs: To suppress or not to suppress? Immunology 2008;124:445–452.
Direct Link:
479
Walker LS. Regulatory T cells overturned: The effectors fight back. Immunology 2009;126:466–474.
Direct Link:
480
Marshall JC. Sepsis: Rethinking the approach to clinical research. J Leukoc Biol 2008;83:471–482.
481
Girbes AR, Beishuizen A, Strack van Schijndel RJ. Pharmacological treatment of sepsis. Fundam Clin Pharmacol 2008;22:355–361.
Direct Link:
482
Wittebole X, Collienne C, Castanares-Zapatero D, et al. Adjunctive therapies for severe sepsis. Int J Antimicrob Agents 2008;32(Suppl 1):S34–S38.

View Full Article (HTML) Get PDF (655K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

The Immunopathology of Sepsis: Pathogen Recognition, Systemic Inflammation, the Compensatory Anti-Inflammatory Response, and Regulatory T Cells

Journal of Veterinary Internal Medicine

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

The Immunopathology of Sepsis: Pathogen Recognition, Systemic Inflammation, the Compensatory Anti-Inflammatory Response, and Regulatory T Cells

Journal of Veterinary Internal Medicine

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this